My Portfolio

Merck & Co Inc MRK:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 6:19 PM EDT

115.01

+0.31 (+0.27%)

Volume

672,568

114.70

-0.95 (-0.82%)

Volume

7,506,900

52 week range

75.44 - 125.14

Open115.45
Day High117.33
Day Low114.70
Prev Close115.65
52 Week High125.14
52 Week High Date02/25/26
52 Week Low75.44
52 Week Low Date06/03/25

Latest On Merck & Co Inc

Investors should take some money off the table, says MAI Capital's Chris Grisanti4 Hours AgoCNBC.com
Barclays on the top takeaways from the annual ASCO conference12 Hours AgoCNBC.com
2026 ASCO Annual Meeting: BofA's Jason Gerberry on what to expectJune 1, 2026CNBC.com
Lung cancer drug from Akeso, Summit cut risk of death by 34% in late-stage trialMay 31, 2026CNBC.com
Jim Cramer looks ahead to next week's market game planMay 29, 2026CNBC.com
Watch CNBC's full interview with Johnson & Johnson Chairman and CEO Joaquin DuatoMay 29, 2026CNBC.com
Graig Suvannavejh: ASCO is one of the highlights of our year in biotechMay 29, 2026CNBC.com
Calls of the Day: Eli Lilly, UnitedHealth and the XBIMay 26, 2026CNBC.com
Dr. Scott Gottlieb on Ebola outbreak: This is an outbreak that's out of control in West AfricaMay 26, 2026CNBC.com
Arm extends weekly rally to almost 50%, and Starbucks pulls plug on an AI projectMay 22, 2026CNBC.com

Key Stats

Market Cap283.289B
Shares Out2.47B
10 Day Average Volume9.96M
Dividend3.40
Dividend Yield2.96%
Beta0.22

Latest On Merck & Co Inc

Investors should take some money off the table, says MAI Capital's Chris Grisanti4 Hours AgoCNBC.com
Barclays on the top takeaways from the annual ASCO conference12 Hours AgoCNBC.com
2026 ASCO Annual Meeting: BofA's Jason Gerberry on what to expectJune 1, 2026CNBC.com
Lung cancer drug from Akeso, Summit cut risk of death by 34% in late-stage trialMay 31, 2026CNBC.com
Jim Cramer looks ahead to next week's market game planMay 29, 2026CNBC.com
Watch CNBC's full interview with Johnson & Johnson Chairman and CEO Joaquin DuatoMay 29, 2026CNBC.com
Graig Suvannavejh: ASCO is one of the highlights of our year in biotechMay 29, 2026CNBC.com
Calls of the Day: Eli Lilly, UnitedHealth and the XBIMay 26, 2026CNBC.com
Dr. Scott Gottlieb on Ebola outbreak: This is an outbreak that's out of control in West AfricaMay 26, 2026CNBC.com
Arm extends weekly rally to almost 50%, and Starbucks pulls plug on an AI projectMay 22, 2026CNBC.com

KEY STATS

Open115.45
Day High117.33
Day Low114.70
Prev Close115.65
52 Week High125.14
52 Week High Date02/25/26
52 Week Low75.44
52 Week Low Date06/03/25
Market Cap283.289B
Shares Out2.47B
10 Day Average Volume9.96M
Dividend3.40
Dividend Yield2.96%
Beta0.22

RATIOS/PROFITABILITY

EPS (TTM)3.55
P/E (TTM)32.27
Fwd P/E (NTM)13.46
EBITDA (TTM)24.713B
ROE (TTM)18.97%
Revenue (TTM)65.768B
Gross Margin (TTM)76.53%
Net Margin (TTM)13.58%
Debt To Equity (MRQ)107.06%

EVENTS

Earnings Date08/04/2026(est)
Ex Div Date06/15/2026
Div Amount0.85
Split Date-
Split Factor-

Content From Our Affiliates

Merck & Company (MRK) Receives a Buy from UBSJune 2, 2026TipRanks
FDA issues draft guidance to help accelerated cell, gene therapies for patientsJune 2, 2026TipRanks
Bernstein Remains a Hold on Merck & Company (MRK)June 2, 2026TipRanks
Scotiabank Sticks to Their Buy Rating for Merck & Company (MRK)June 2, 2026TipRanks
Merck & Company (MRK) Receives a Buy from GuggenheimJune 2, 2026TipRanks

Profile

Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines...

Robert Davis

Chairman of the Board, President, Chief Executive Officer

Caroline Litchfield

Executive Vice President, Chief Financial Officer

Dean Li M.D., Ph.D.

Executive Vice President, President - Merck Research Laboratories

Chirfi Guindo

Executive Vice President - Strategic Access, Policy & Communications

David Maraldo

Executive Vice President, President, Merck Manufacturing Division

Address

126 East Lincoln Avenue,

P.O. Box 2000

Rahway, NJ

07065

United States

https://www.merck.com/